165 related articles for article (PubMed ID: 36265907)
1. Adverse Clinical Events at the Injection Site Are Exceedingly Rare After Reported Radiopharmaceutical Extravasation in Patients Undergoing
Parihar AS; Schmidt LR; Crandall J; Dehdashti F; Wahl RL
J Nucl Med; 2023 Mar; 64(3):485-490. PubMed ID: 36265907
[TBL] [Abstract][Full Text] [Related]
2. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
Ergün EL; Kiratli PO; Günay EC; Erbaş B
Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428
[TBL] [Abstract][Full Text] [Related]
3. Intra-individual comparison of
Bénard F; Harsini S; Wilson D; Zukotynski K; Abikhzer G; Turcotte E; Cossette M; Metser U; Romsa J; Martin M; Mar C; Saad F; Soucy JP; Eigl BJ; Black P; Krauze A; Burrell S; Nichol A; Tardif JC
Lancet Oncol; 2022 Dec; 23(12):1499-1507. PubMed ID: 36343655
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
5. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
[TBL] [Abstract][Full Text] [Related]
6. Dual-phase (99m)Tc-MIBI scintigraphy with delayed neck and thorax SPECT/CT and bone scintigraphy in patients with primary hyperparathyroidism: correlation with clinical or pathological variables.
Qiu ZL; Wu B; Shen CT; Zhu RS; Luo QY
Ann Nucl Med; 2014 Oct; 28(8):725-35. PubMed ID: 25120244
[TBL] [Abstract][Full Text] [Related]
7. Accurate characterization of
Zhang L; He Q; Zhou T; Zhang B; Li W; Peng H; Zhong X; Ma L; Zhang R
BMC Med Imaging; 2019 May; 19(1):44. PubMed ID: 31146746
[TBL] [Abstract][Full Text] [Related]
8. Incidental 99mTc MDP uptake in the intestines and intravenous CT contrast.
Kim SJ; Choi JY; Lee JH; Hyun SH; Cho YS; Moon SH; Choe YS; Lee KH; Kim BT
Nuklearmedizin; 2016 Aug; 55(4):166-71. PubMed ID: 26632485
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of Na[
Usmani S; Ahmed N; Gnanasegaran G; Al Kandari F; Marafi F; Bani-Mustafa A; Musbah A; Jassem Almashmoum M; Van den Wyngaert T
Acta Oncol; 2022 Oct; 61(10):1230-1239. PubMed ID: 35862646
[TBL] [Abstract][Full Text] [Related]
10. Compartment syndrome caused by computed tomography contrast infiltration seen on a Tc-99m methylene diphosphonate bone scan.
Gerard PS; Gerczuk PZ; Idupuganti R; Patnana M; Geller MD
Clin Nucl Med; 2008 Jan; 33(1):36-7. PubMed ID: 18097256
[TBL] [Abstract][Full Text] [Related]
11. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
[TBL] [Abstract][Full Text] [Related]
12. Head-to-head comparison of
Zhang Y; Lin Z; Li T; Wei Y; Yu M; Ye L; Cai Y; Yang S; Zhang Y; Shi Y; Chen W
Sci Rep; 2022 Sep; 12(1):15993. PubMed ID: 36163353
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. The value of
Zhang L; He Q; Li W; Zhang R
BMC Med Imaging; 2017 Jul; 17(1):46. PubMed ID: 28738834
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of 99mTc-MDP SPECT/spiral CT combined with three-phase bone scintigraphy in assessing suspected bone tumors in patients with no malignant history.
Zhang Y; Shi H; Li B; Xiu Y; Cai L; Gu Y; Chen S
Nucl Med Commun; 2015 Jul; 36(7):686-94. PubMed ID: 25757199
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Bone Metastases between
Wang D; Yang Y; Zeng Z; Ye J; Guo C; Huang S; Guo X; Xiao J
Contrast Media Mol Imaging; 2022; 2022():5975338. PubMed ID: 35494210
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric considerations of
Brown JL; Sexton-Stallone B; Li Y; Frey EC; Treves ST; Fahey FH; Plyku D; Cao X; Choi C; Kim CH; Sgouros G; Aris JP; Bolch WE
Phys Med Biol; 2020 Dec; 65(23):235025. PubMed ID: 33263312
[TBL] [Abstract][Full Text] [Related]
18. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
Lee JW; Lee SM; Lee HS; Kim YH; Bae WK
Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma.
Franzius C; Bielack S; Flege S; Sciuk J; Jürgens H; Schober O
J Nucl Med; 2002 Aug; 43(8):1012-7. PubMed ID: 12163625
[TBL] [Abstract][Full Text] [Related]
20. Role of
Parghane RV; Singh B; Sharma A; Singh H; Singh P; Bhattacharya A
J Nucl Med Technol; 2017 Dec; 45(4):280-284. PubMed ID: 28798229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
